• slide
  • slide

At Sanarus Technologies we think that women deserve a better outcome.

Our Story:
Sanarus has developed, patented, and tested a proprietary minimally invasive breast therapy system. The Visica 2TMTreatment System is an image-guided cryoablation device for the treatment of breast tumors as an alternative to surgical lumpectomy. This breast conserving treatment is available at participating breast centers throughout the U.S. To find a physician near you who specializes in this procedure, please contact us at 800-909-3060 or support(at)sanarus.com.

The NCI sponsored ACOSOG Z1072 study used Visica cryoablation to treat early-stage breast cancers. Its recent completion yielded promising results- 93.4% of breast tumors <1 cm had complete ablation.4

The Visica 2 Treatment System has FDA clearance for the ablation of cancerous or malignant tissue and benign tumors . Sanarus is currently sponsoring the FROST Clinical Study for early stage breast cancer that does not involve surgical resection. For more information about the FROST Clinical Study, click here.

A message from our Chairman...

"Being a woman, I understand that this may be a very difficult time for you and your family. That's why we are committed to give you the information and education you need to make an informed decision. We welcome you to contact us today with your questions and we will do our best to help you."


BJ Hardman

Cryotherapy Procedure featuring Dr. Charles Cox of USF